In the sphere of immuno-oncology research, a powerful tool has emerged - the Diet-Induced Obesity (DIO) mouse model. These models provide researchers a practical route to understanding the connections between obesity, immunity, and cancer treatment. The real value of DIO mice lies in their ability to reflect human-like responses, marking a new phase of discovery. Below are the top 5 reasons researchers should be incorporating DIO mice into the preclinical evaluation of immuno-oncology treatments.
Unveiling the Potential: 5 Ways DIO Mice Enhance Immuno-Oncology Discoveries
August 22, 2023
- Live Dead Measurement and Cell Viability
- To Fc or not Fc: An assay for the question
- Fc Receptors (FcR) and their Relevance to Flow Cytometry
- Large Panel Design to Identify Human and Mouse Lymphocyte Subsets Using Cytek® Aurora Flow Cytometers
- Featured Guest Blog: Cardiac Stem Cells by Darcey L. Clark
Live Dead Measurement and Cell Viability
By Marrisssa Bailey, BS
To Fc or not Fc: An assay for the question
By Shalina Prasad BS
Fc Receptors (FcR) and their Relevance to Flow Cytometry
By Jennifer J. Stewart PhD
Get Started
Contact Us Today!
If you’re looking for an expert team to guide your trial with efficiency in mind, we can help. As the creators of the Dynamic Trial, TD2 provides start-to-finish support with trial strategy, design and execution for faster go-to-market potential.